Shared news with a friend who is a kidney specialist doctor. Here is their brief reply.
“I only read abstract papers on the third phase test of DMX-200, but I honestly didn't realise how effective it was.CCR2 inhibitors have been studied for other nephritis, and we often experience cases where it is difficult to treat FSGS and lead to dialysis, so I'm looking forward to it!”
Hope that FUSO is able to get the word out and recruit quickly. Let’s see the patients lives improved, dara and next milestones.
DXB Price at posting:
58.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)